About this trial
The purpose of this study is to understand whether Black participants with insomnia with objective short-sleep (ISSD) experience less symptom improvement in response to Cognitive Behavioral Therapy for Insomnia (CBTi) than Insomnia with Normal Sleep Duration (INSD) and whether this difference is driven by downstream racism-related stress and experiences. The investigators propose an innovative pragmatic open-label design in which Black participants with insomnia undergo a standard 6-week protocol of digital CBTi. The investigators will quantify ISSD using wireless EEG and will gather high-resolution naturalistic data of racism-related stress using random smartphone prompts and Ecological Momentary Assessments (EMA).
Eligibility criteria
Qualifiers
Non-Hispanic Black adults
aged 18-65 years with
Clinically Significant [Insomnia Severity Index (ISI) score > 1048] insomnia symptoms and
clinically significant depressive symptoms [PHQ-9 total score >9].
Disqualifiers
Current alcohol or substance use issues,
Current active suicidal ideation
Current shift-worker or frequent time zone travel
Severe psychiatric morbidity within 6 months or lifetime history of bipolar disorder, mania, psychotic disorder
Trial design
Treatments tested in this trial
- Cognitive Behavioral Therapy for Insomnia (CBTi)
Treatment groups
Locations
Sponsors and collaborators
Johns Hopkins University
Lead sponsor
American Academy of Sleep Medicine
Collaborator